Bilateral salpingectomy can reduce the risk of ovarian cancer in the general population: A meta-analysis

European Journal of Cancer

Volumn 55, Issue , 2016, Pages 38-46

  Yoon, Sang Hee ^a   Kim, Soo Nyung ^b   Shim, Seung Hyuk ^b   Kang, Soon Beum ^b   Lee, Sun Joo ^b  

^a Inje University College of Medicine   (South Korea)

^b Konkuk University School of Medicine   (South Korea)

Author keywords

Meta analysis; Ovarian cancer; Salpingectomy

Indexed keywords

ARTICLE; BILATERAL SALPINGECTOMY; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; FEMALE; HUMAN; HYSTERECTOMY; META ANALYSIS; OVARIECTOMY; OVARY CANCER; POPULATION; PRIORITY JOURNAL; PROPHYLACTIC SURGICAL PROCEDURE; RISK REDUCTION; SALPINGECTOMY; SYSTEMATIC REVIEW; UTERINE TUBE; ODDS RATIO; OVARIAN NEOPLASMS; PROCEDURES; PROTECTION; RISK ASSESSMENT; RISK FACTOR;

FEMALE; HUMANS; ODDS RATIO; OVARIAN NEOPLASMS; PROTECTIVE FACTORS; RISK ASSESSMENT; RISK FACTORS; SALPINGECTOMY;

EID: 84953896523     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2015.12.003     Document Type: Article

References (64)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2012 CA: A Cancer Journal for Clinicians 62 1 2012 10 29
2. H. Falconer, L. Yin, H. Gronberg, and D. Altman Ovarian cancer risk after salpingectomy: a nationwide population-based study J Natl Cancer Inst 107 2 2015 Jan 27 10.1093/jnci/dju410 Print 2015 Feb
3. A.D. Findley, M.T. Siedhoff, K.A. Hobbs, J.F. Steege, E.T. Carey, C.A. McCall, and et al. Short-term effects of salpingectomy during laparoscopic hysterectomy on ovarian reserve: a pilot randomized controlled trial Fertility and sterility 100 6 2013 Dec 1704 1708
4. J.M. Piek, P.J. van Diest, R.P. Zweemer, J.W. Jansen, R.J. Poort-Keesom, F.H. Menko, and et al. Dysplastic changes in prophylactically removed fallopian tubes of women predisposed to developing ovarian cancer J Pathol 195 4 2001 Nov 451 456
5. J.W. Carlson, A. Miron, E.A. Jarboe, M.M. Parast, M.S. Hirsch, Y. Lee, and et al. Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention J Clin Oncol 26 25 2008 Sep 1 4160 4165
6. D.A. Levine, P.A. Argenta, C.J. Yee, D.S. Marshall, N. Olvera, F. Bogomolniy, and et al. Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations J Clin Oncol 21 22 2003 Nov 15 4222 4227
7. D.D. Bowtell The genesis and evolution of high-grade serous ovarian cancer Nat Rev Cancer 10 11 2010 Nov 803 808
8. R.J. Kurman, and I. Shih Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer - shifting the paradigm Hum Pathol 42 7 2011 918 931
9. A.A. Tone, S. Salvador, S.J. Finlayson, A.V. Tinker, J.S. Kwon, C.H. Lee, and et al. The role of the fallopian tube in ovarian cancer Clin Adv Hematol Oncol 10 5 2012 May 296 306
10. Y. Lee, A. Miron, R. Drapkin, M.R. Nucci, F. Medeiros, A. Saleemuddin, and et al. A candidate precursor to serous carcinoma that originates in the distal fallopian tube J Pathol 211 1 2007 Jan 26 35
11. Mehrad M. A pathologist's road map to benign, precancerous, and malignant intraepithelial proliferations in the fallopian tube.
12. J. Li, O. Fadare, L. Xiang, B. Kong, and W. Zheng Ovarian serous carcinoma: recent concepts on its origin and carcinogenesis J Hematol Oncol 5 8 2012 Mar 9 8722-5-8
13. D.F. Stroup, J.A. Berlin, S.C. Morton, I. Olkin, G.D. Williamson, D. Rennie, and et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. meta-analysis of observational studies in epidemiology (MOOSE) group JAMA 283 15 2000 Apr 19 2008 2012
14. D. Moher, A. Liberati, J. Tetzlaff, and D.G. Altman PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement PLoS Med 6 7 2009 Jul 21 e1000097
15. J. Higgins, and S. Green Cochrane handbook for systematic reviews of interventions version 5.1. 0 [updated March 2011] 2011 The Cochrane Collaboration www.cochrane-handbook.org 2014
16. G. Wells, B. Shea, D. O'connell, J. Peterson, V. Welch, M. Losos, and et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses 2000
17. O. Aziz, V. Constantinides, P.P. Tekkis, T. Athanasiou, S. Purkayastha, P. Paraskeva, and et al. Laparoscopic versus open surgery for rectal cancer: a meta-analysis Ann Surg Oncol 13 3 2006 Mar 413 424
18. G.A. Millett, S.A. Flores, G. Marks, J.B. Reed, and J.H. Herbst Circumcision status and risk of HIV and sexually transmitted infections among men who have sex with men: a meta-analysis JAMA 300 14 2008 Oct 8 1674 1684
19. J.P. Higgins, and S.G. Thompson Quantifying heterogeneity in a meta-analysis Stat Med 21 11 2002 Jun 15 1539 1558
20. J.P. Higgins, S.G. Thompson, J.J. Deeks, and D.G. Altman Measuring inconsistency in meta-analyses BMJ 327 7414 2003 Sep 6 557 560
21. C.B. Begg, and M. Mazumdar Operating characteristics of a rank correlation test for publication bias Biometrics 50 4 1994 Dec 1088 1101
22. M. Egger, G. Davey Smith, M. Schneider, and C. Minder Bias in meta-analysis detected by a simple, graphical test BMJ 315 7109 1997 Sep 13 629 634
23. R.G. Orwin A fail-safe N for effect size in meta-analysis Journal of educational statistics 1983 157 159
24. J.A. Sterne, and M. Egger Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis J Clin Epidemiol 54 10 2001 Oct 1046 1055
25. J.A. Sterne, M. Egger, and G.D. Smith Systematic reviews in health care: investigating and dealing with publication and other biases in meta-analysis BMJ 323 7304 2001 Jul 14 101 105
26. Committee opinion no. 620 Salpingectomy for ovarian cancer prevention Obstetrics and gynecology 125 1 2015 Jan 279 281
27. F.J. Backes Salpingectomy, why not? Am J Obstet Gynecol 210 5 2014 May 385 386
28. S.V. Blank Prophylactic and risk-reducing bilateral salpingo-oophorectomy: recommendations based on risk of ovarian cancer Obstet Gynecol 117 2 Pt 1 2011 Feb 404 author reply 404
29. Advocating fallopian tube removal at the time of hysterectomy to prevent ovarian cancer [homepage on the Internet]. Available from: http://www.ovcare.ca/prevention/.
30. E.J. Tanner, K.C. Long, K. Visvanathan, and A.N. Fader Prophylactic salpingectomy in premenopausal women at low risk for ovarian cancer: risk-reducing or risky? Fertil Steril 100 6 2013 Dec 1530 1531
31. I.M. Collins, S.M. Domchek, D.G. Huntsman, and G. Mitchell The tubal hypothesis of ovarian cancer: caution needed Lancet Oncol 12 12 2011 Nov 1089 1091
32. S.A. Narod Salpingectomy to prevent ovarian cancer: a countercurrents series Curr Oncol 20 3 2013 Jun 145 147
33. T.J. Herzog, and H.E. Dinkelspiel Fallopian tube removal: "Stic-ing" it to ovarian cancer: what is the utility of prophylactic tubal removal? Curr Oncol 20 3 2013 Jun 148 151
34. M. Monist, P. Skorupski, J. Tomaszewski, D. Lewkowicz, and T. Rechberger Bilateral salpingectomy as a prophylaxis of malignancy in patients operated for benign gynecological conditions. Primary serous intraepithelial carcinoma of the fallopian tubes-case report International Journal of Gynecological Cancer 23 8 Suppl. 1 2013 1037-
35. J. Dietl, J. Wischhusen, and S.F. Hausler The post-reproductive fallopian tube: better removed? Hum Reprod 26 11 2011 Nov 2918 2924
36. C.K. Anderson, S. Wallace, M. Guiahi, J. Sheeder, K. Behbakht, and M.A. Spillman Risk-reducing salpingectomy as preventative strategy for pelvic serous cancer Int J Gynecol Cancer 23 3 2013 Mar 417 421
37. C.P. Crum, R. Drapkin, D. Kindelberger, F. Medeiros, A. Miron, and Y. Lee Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer Clin Med Res. 5 1 2007 Mar 35 44
38. S.E. Gill, and B.B. Mills Physician opinions regarding elective bilateral salpingectomy with hysterectomy and for sterilization J Minim Invasive Gynecol 20 4 2013 Jul-Aug 517 521
39. J.N. McAlpine, M. Witheford, A.A. Tone, D.G. Huntsman, D.M. Miller, and Finlayson Risk-reducing salpingectomy in low risk patients: assessing the impact of a novel request for surgical practice change International Journal of Gynecological Cancer 22 Suppl. 3 2012 E326-
40. S. Kapurubandara, V. Qin, D. Gurram, A. Anpalagan, H. Merkur, R. Hogg, and A. Brand Opportunistic bilateral salpingectomy during gynaecological surgery for benign disease: a survey of current Australian practice International Journal of Gynecological Cancer 24 9 Suppl. 4 2014 233-
41. M.E. Sherman, M. Piedmonte, P.L. Mai, O.B. Ioffe, B.M. Ronnett, L. Van Le, and et al. Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from gynecologic oncology group trial GOG-0199 J Clin Oncol 32 29 2014 Oct 10 3275 3283
42. M.H. Greene, P.L. Mai, and P.E. Schwartz Does bilateral salpingectomy with ovarian retention warrant consideration as a temporary bridge to risk-reducing bilateral oophorectomy in BRCA1/2 mutation carriers? Am J Obstet Gynecol 204 1 2011 Jan 19.e1,19.e6
43. I. Vyarvelska, B. Rosen, and S.A. Narod Should hysterectomy complement prophylactic salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers? Gynecol Oncol 134 2 2014 Aug 219 221
44. A. Obermair, D.R. Youlden, P.D. Baade, and M. Janda The impact of risk-reducing hysterectomy and bilateral salpingo-oophorectomy on survival in patients with a history of breast cancer-a population-based data linkage study Int J Cancer 134 9 2014 May 1 2211 2222
45. F. Chiaffarino, F. Parazzini, A. Decarli, S. Franceschi, R. Talamini, M. Montella, and et al. Hysterectomy with or without unilateral oophorectomy and risk of ovarian cancer Gynecol Oncol 97 2 2005 May 318 322
46. A.S. Whittemore, R. Harris, and J. Itnyre Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative ovarian cancer group Am J Epidemiol 136 10 1992 Nov 15 1184 1203
47. S. Salvador, B. Gilks, M. Kobel, D. Huntsman, B. Rosen, and D. Miller The fallopian tube: primary site of most pelvic high-grade serous carcinomas Int J Gynecol Cancer 19 1 2009 Jan 58 64
48. Rice MS. Tubal ligation, hysterectomy, unilateral oophorectomy, and risk of ovarian cancer in the nurses' health studies.
49. M.S. Rice, M.A. Murphy, and S.S. Tworoger Tubal ligation, hysterectomy and ovarian cancer: a meta-analysis J Ovarian Res. 5 1 2012 May 15 13, 2215-5-13
50. M.S. Rice, M.A. Murphy, A.F. Vitonis, D.W. Cramer, L.J. Titus, S.S. Tworoger, and et al. Tubal ligation, hysterectomy and epithelial ovarian cancer in the new England case-control study Int J Cancer 133 10 2013 Nov 15 2415 2421
51. W. Sieh, S. Salvador, V. McGuire, R.P. Weber, K.L. Terry, M.A. Rossing, and et al. Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies Int J Epidemiol 42 2 2013 Apr 579 589
52. M. Sezik, O. Ozkaya, F. Demir, H.T. Sezik, and H. Kaya Total salpingectomy during abdominal hysterectomy: effects on ovarian reserve and ovarian stromal blood flow J Obstet Gynaecol Res 33 6 2007 Dec 863 869
53. J.N. McAlpine, G.E. Hanley, M.M. Woo, A.A. Tone, N. Rozenberg, K.D. Swenerton, and et al. Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention Am J Obstet Gynecol 210 5 2014 May 471.e1,471.11
54. J.N. McAlpine, A.E. Tone, N. Rozenberg, G. Hanley, M. Heywood, and G. Gilks Stuart Opportunistic salpingectomy: impact of a regional program for ovarian cancer prevention International Journal of Gynecological Cancer 23 8 Suppl. 1 2013 1035-
55. R. Guldberg, S. Wehberg, C.W. Skovlund, O. Mogensen, and O. Lidegaard Salpingectomy as standard at hysterectomy? A Danish cohort study, 1977-2010 BMJ open 3 6 2013
56. J.T. Rabban, K. Garg, B. Crawford, L.M. Chen, and C.J. Zaloudek Early detection of high-grade tubal serous carcinoma in women at low risk for hereditary breast and ovarian cancer syndrome by systematic examination of fallopian tubes incidentally removed during benign surgery Am J Surg Pathol 38 6 2014 Jun 729 742
57. J.S. Kwon, J.N. McAlpine, G.E. Hanley, S.J. Finlayson, T. Cohen, D.M. Miller, and et al. Costs and benefits of opportunistic salpingectomy as an ovarian cancer prevention strategy Obstet Gynecol 125 2 2015 Feb 338 345
58. C.R. Lessard-Anderson, K.S. Handlogten, R.J. Molitor, S.C. Dowdy, W.A. Cliby, A.L. Weaver, and et al. Effect of tubal sterilization technique on risk of serous epithelial ovarian and primary peritoneal carcinoma Gynecol Oncol 135 3 2014 Dec 423 427
59. C. Madsen, L. Baandrup, C. Dehlendorff, and S.K. Kjaer Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case-control study Acta Obstet Gynecol Scand 94 1 2015 Jan 86 94
60. J. Vorwergk, M.P. Radosa, K. Nicolaus, N. Baus, J. Jimenez Cruz, M. Rengsberger, and et al. Prophylactic bilateral salpingectomy (PBS) to reduce ovarian cancer risk incorporated in standard premenopausal hysterectomy: complications and re-operation rate J Cancer Res Clin Oncol 140 5 2014 May 859 865
61. R. Scully, R. Young, and P. Clement Tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligament: atlas of tumor pathology. Fascicle 23 3rd series ed 1998 Armed Forces Institute of Pathology
62. J. Kim, D.M. Coffey, C.J. Creighton, Z. Yu, S.M. Hawkins, and M.M. Matzuk High-grade serous ovarian cancer arises from fallopian tube in a mouse model Proc Natl Acad Sci U S A 109 10 2012 Mar 6 3921 3926
63. Parker WH. Long-term mortality associated with oophorectomy compared with ovarian conservation in the nurses' health study.
64. Morelli M. Prophylactic salpingectomy in premenopausal low-risk women for ovarian cancer: primum non nocere.